Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001628280-25-050668

Director sold 16,575 shares at an average $484.30 ($8,027,354)

  • Director acquired 16,575 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BATE KENNETH Director 2025-11-05 Option exercise +5,470 $9.45 $51,692 8,097 D
BATE KENNETH Director 2025-11-05 Option exercise +10,000 $303.79 $3,037,900 18,097 D
BATE KENNETH Director 2025-11-05 Option exercise +1,105 $280.04 $309,444 19,202 D
BATE KENNETH Director 2025-11-05 Sale −1,763 $480.24 $846,663 17,439 D
BATE KENNETH Director 2025-11-05 Sale −3,259 $481.13 $1,567,995 14,180 D
BATE KENNETH Director 2025-11-05 Sale −1,284 $482.41 $619,417 12,896 D
BATE KENNETH Director 2025-11-05 Sale −2,069 $483.41 $1,000,170 10,827 D
BATE KENNETH Director 2025-11-05 Sale −1,931 $484.78 $936,105 8,896 D
BATE KENNETH Director 2025-11-05 Sale −1,008 $485.54 $489,421 7,888 D
BATE KENNETH Director 2025-11-05 Sale −827 $486.73 $402,530 7,061 D
BATE KENNETH Director 2025-11-05 Sale −2,775 $487.49 $1,352,796 4,286 D
BATE KENNETH Director 2025-11-05 Sale −696 $489.09 $340,409 3,590 D
BATE KENNETH Director 2025-11-05 Sale −933 $489.95 $457,119 2,657 D
BATE KENNETH Director 2025-11-05 Sale −30 $490.98 $14,729 2,627 D
Derivatives
BATE KENNETH Director 2025-11-05 Option exercise · Stock Option (Right to Buy) −5,470 0 D
BATE KENNETH Director 2025-11-05 Option exercise · Stock Option (Right to Buy) −10,000 0 D
BATE KENNETH Director 2025-11-05 Option exercise · Stock Option (Right to Buy) −1,105 0 D
Open-market sales · 16,575 sh · avg $484.30 · $8,027,354
Loading xslF345X05/wk-form4_1762550418.xml…